Search for Stocks /

Patanjali Foods FY26: ₹40,000 Crore in Revenue, Margins Under Siege

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.


1. At a Glance

Patanjali Foods crossed ₹40,000 crore in revenue for the first time in FY26, but the headline hides the real story. Operating margins compressed to 4.4%, down from 6% in FY22, even as the company scaled oils, biscuits, and a newly integrated Home & Personal Care division. Profit after tax jumped 39% to ₹1,815 crore, but this owes more to a tax refund windfall (₹788 crore related to CIRP-era claims) than to operational ferocity.

Edible oils remain the engine—₹29,314 crore in revenue, or 73% of total sales—yet they’re also the margin grinder. Input costs on crude palm and soya have swung wildly. Management guided a narrow 2–4% EBITDA band for oils in FY27. FMCG (biscuits, staples, ghee, HPC) is the profit jewel—27% of revenue but 61% of FY26 EBITDA—and it’s growing faster, but it started from near-zero scale three years ago.

The balance sheet is clean: debt sits at ₹788 crore, net of which the company holds ₹413 crore in cash. Interest coverage is robust at 23x. Yet GST litigation hangs over the company: ₹1,353 crore demands were raised across states in FY23, though the largest Chennai demand was recently dropped. Shareholding is tight—promoters at 68.25%, down from 80.82% in June 2023—and FII holding has halved to 9.2% from its 14.4% peak.

The question isn’t scale; it’s pricing power and mix. Can FMCG reach the 15%+ margins management targets while oils drift south? Read on.


2. Introduction

Ruchi Soya became Patanjali Foods in 2019 when the Patanjali Group acquired it through the Corporate Insolvency Resolution Process (CIRP) for ₹4,450 crore. The company inherited a crippled oil business (old Ruchi had swung between losses and tax oddities) and a distribution network in ruins.

Since then, the Patanjali Group has seeded it with biscuits (Doodh), staples (atta, rice, salt), ghee, Nutrela (soya protein), and in FY26, the Home & Personal Care portfolio—dental care (Dant Kanti, Kabaddi), skin care, hair oil, and home care. This wasn’t organic growth; it was inorganic retrofitting. Revenue grew 20% CAGR over five years. Profit grew 24% CAGR, though denominated by tax shenanigas and one-off gains.

The company also owns or controls 110,722 hectares of oil palm plantation (68% cultivated), crushing its own fruit and selling refined palm oil back into the branded market. A strategic hedge against import bills and global volatility, management frames it as part of “Atmanirbhar Bharat.”

Distribution footprint: 8,000+ distributors, 1 million retail touchpoints (up from 0.5 million in FY21), and 3,420 Arogya Kendras and Grameen Arogya Kendras. The network is lean compared to Marico’s 13,611 crore revenue from a vastly tighter footprint, but scale is accelerating.


3. Business Model: WTF Do They Even Do?

Three legs.

Leg 1: Edible Oils (73% of FY26 revenue)

Branded oils (palm, soya, sunflower) under Ruchi, Mahakosh, Patanjali, Nutrela, and Sunrich. Management pegs branded oils as “almost 100% pass-through” on input costs—a fancy way of saying they’re stuck in a commodity margin trap. Buy refined palm at ₹150/liter, sell at ₹152, pocket ₹2, and hope volumes don’t crater.

FY26 edible oil revenue was ₹29,314 crore. Volumes: 20.3 lakh MT (up 8% YoY). That’s heavy tonnage moving through a system of traders, wholesalers, and small retailers who see oil as a loss leader. Margins on edible oils: 2.58% EBITDA in Q4, oscillating between 2–4% annually.

The company also sells oleochemicals (castor-based derivatives for industrial use) and runs 5 palm crushing mills. This sub-leg contributed ₹1,793 crore (oil palm plantation revenue) with a healthier 20% EBITDA margin—EBITDA of ₹357 crore. Planted area is rising (110,722 hectares as of Mar 2026, +24% YoY). Mature acreage (7–25 years old) now comprises 38% of cultivated area. As trees age into yield, margins in this sub-leg will widen.

Leg 2: Foods & Staples (17% of FY26 revenue)

Atta (₹848 crore in Q4), rice, salt, honey, ghee, tea, sauces, and soya texturized products (Nutrela, ₹527 crore in FY26). Ghee accounted for ₹1,424 crore in FY26. Management flagged seasonal softness in Q4—early summer, rice category decline—and noted that El Niño-like conditions and government staple policies pose forward headwinds.

Leg 3: Biscuits (5% of revenue, ₹1,908 crore, +16% YoY)

Doodh biscuits (flagship): ₹1,300+ crore in FY26 (up from ₹1,000 crore in FY25). Sold through 1+ million retail points. Management noted Q4 seasonal softness (“peak summer months”); expects Q1 to bounce. EBITDA margin on biscuits: north of 13%.

Leg 4: Home & Personal Care (integrated in FY26, 7% of revenue)

Dental care (₹1,413 crore, Dant Kanti, Kabaddi): oral care is a growth category for the company. Skin care (₹680 crore, +58% YoY in Q4): management called it “emerging breakout” and a “strategic focus.” Hair care, home care, and others: ₹568 crore. This segment sits at 10.8% EBITDA margin, headed toward 18%+ as efficiencies kick in.

The Mix Tension

Oils drag down blended margins despite huge revenue. FMCG pulls them up. FY26 EBITDA (ex-exceptionals) was ₹1,932 crore on ₹40,170 crore revenue = 4.8% blended margin. Remove oils, and FMCG margins run 10–13%. The longer FMCG as a revenue share stays below 40–50%, the lower the blended floor. This is the company’s arithmetic problem: grow oils to hit scale targets, or shift the portfolio to hit margin targets?


4. Financials Overview

Figures are consolidated, in ₹ crore. Report type: Annual (FY26), basis: Consolidated.

MetricFY24FY25FY26FY26 QoQFY26 YoY
Revenue31,74234,15740,170+17.6%
EBITDA (ex-excp.)2,0461,932-5.6%
PAT (Reported)7651,3011,815+39.5%
EPS (annualized)7.0511.9816.68+39.2%

Q4 FY26 (Jan–Mar 2026):

MetricQ4 FY26YoYQoQ
Revenue11,156+15.1%
Operating Profit445-4.4%+2.3%
PAT524+154%+11.5%
EPS (annualized)4.82+154%

The 154% EPS jump in Q4 is tax-driven (refunds of ₹330 crore in the quarter). Stripping that out, operational PAT would be ₹236 crore, a more pedestrian +5% growth. Margin pressure was acute: Cost of Goods Sold rose 294 bps YoY, blamed on crude-linked input costs (palm, soya) and secondary inflation in packaging, freight, and insurance.

Management called out input inflation in April 2026 (post-quarter): palm oils up 15% YoY, soybean +17%, sunflower +22%, all linked to geopolitical disruption and Indonesia’s proposed biodiesel push (B45). In response, the company raised prices “almost on a daily basis… almost 100% pass-through,” yet the gap between input cost rises and pricing traction creates a lag-driven margin

Read Full 16 Point breakdown. Continue reading →
Members get full access to every article.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →